'Comparing serotype coverage of pneumococcal vaccines with PCV21 (V116), a new 21-valent conjugate pneumococcal vaccine, and the epidemiology of its eight unique Streptococcus pneumoniae serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) causing invasive pneumococcal disease in adult patients in Canada: SAVE study, 2018–2021-right-to-reply'
Saved in:
| Title: | 'Comparing serotype coverage of pneumococcal vaccines with PCV21 (V116), a new 21-valent conjugate pneumococcal vaccine, and the epidemiology of its eight unique Streptococcus pneumoniae serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) causing invasive pneumococcal disease in adult patients in Canada: SAVE study, 2018–2021-right-to-reply' |
|---|---|
| Authors: | Schellenberg, John J1 (AUTHOR), Adam, Heather J2 (AUTHOR), Baxter, Melanie R1 (AUTHOR), Karlowsky, James A2 (AUTHOR), Zhanel, George G1 (AUTHOR) |
| Source: | Journal of Antimicrobial Chemotherapy (JAC). Apr2026, Vol. 81 Issue 4, p1-1. 1p. |
| Database: | Environment Complete |
| ISSN: | 03057453 |
|---|---|
| DOI: | 10.1093/jac/dkag126 |
